MCK vs NERV · P/E 20, rev $403.43B vs P/E 2.2, $12.4M cap
McKesson Corporation (MCK) versus Minerva Neurosciences Inc (NERV) — a side-by-side from cached financials, not a winner call.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Minerva Neurosciences Inc (NERV) is a biotechnology company listed on US.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
NERV does not have a complete income-statement cache yet.
MCK currently screens at market cap $91.30B and trailing P/E 20.3. NERV currently screens at market cap $12.4M and trailing P/E 2.2.
Not investment advice. Open the MCK and NERV stock pages for the full models.
Not investment advice.